Law360, New York (January 10, 2011, 6:31 PM ET) -- A former InterMune Inc. CEO convicted of fraudulently marketing one of his company’s drugs for a deadly lung disease is fighting for a new trial, saying the U.S. government unlawfully delayed releasing documents that could have cleared his name.
Dr. W. Scott Harkonen moved for a new trial Friday in the U.S. District Court for the Northern District of California, claiming prosecutors failed to turn over 67 pages of documents from the U.S. Department of Veterans Affairs that allegedly proved an August 2002 InterMune press release...
Ex-InterMune CEO Says Withheld Docs Clear His Name
To view the full article, take a free trial now.
